Skip to main content


University Hospital

Nicolas Demartines, MD
Professor and CEO

Welcome to the University Hospital of Lausanne, Switzerland, better known here as “CHUV”. Our hospital is located in the heart of the Leman Lake “Health Valley”, around Lausanne, a charming city on Leman Lake. Since 2019, our hospital has been ranked among the top best hospitals in the world, according to the US magazine Newsweek.

The CHUV is one of five Swiss academic public health care centers, and plays a leading role in the fields of medical care, research, teaching and training, in collaboration with the Faculty of Biology and Medicine at the University of Lausanne.

With its mission lying at the crossroads between medicine, sciences and humanities, CHUV offers a personalized approach to patient care. Several national and international collaborations allow us to deliver the best possible care to our patients.

We hope that this website and the “In Vivo” selection of projects will be of interest to you. Our vision is to promote the medicine of tomorrow in the best interest of patients and their relatives.


Key numbers

Explore our hospital’s 2022 profile via a few key figures.



billion (annual budget in Swiss francs)



patients hospitalised







Overview of innovative projects

From bio-bandages for people suffering from severe burns to new weapons against cancer, discover the In Vivo magazine's selection of innovative projects from the CHUV "incubator".

Brain Computer Interface enables thought-controlled walking after spinal cord injury

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report that they have re-established the communication between the brain and spinal cord with a wireless digital bridge, allowing a paralyzed person to walk again naturally.

Read more

Pushing the Boundaries of Innovation for Brain Tumor Research

The neuro-oncology team at the CHUV is intensely involved in international and in-house clinical trials. Clinical trials represent an important opportunity for patients who can potentially benefit from the latest advances in the field.

Read more

How does our brain produce dreams?

At our Center for Sleep Investigation and Research, Professor Francesca Siclari has been awarded two grants between 2021 and 2022, including a prestigious ERC Starting Grant, for her research on mechanisms at the origin of dreams.

Read more

An in vivo microscope of brain activity, using MRI

In the Department of Medical Radiology, Professor Ileana Jelescu has received an ERC Starting Grant 2022 to develop FIREPATH, the first non-invasive technique to map activity in the brain white matter on a clinical MRI.

Read more

Coordinating the Swiss arm of “Solidarity”

Supported by the Swiss National Science Foundation (NSF) and in collaboration with the Federal Office of Public Health (FOPH), CHUV is coordinating Switzerland’s participation in the “Solidarity” study.

Read more

Understanding the impact of COVID-19 on pregnancy

CHUV has created the “International COVID-19 and Pregnancy Registry” (COVI-Preg), which aims to assess the impact of SARS-CoV 2 on pregnancy and the health of mothers and newborns.

Read more

Providing better support for people during a pandemic

The “Collaborative Outcomes Study on Health and Functioning during Infection Times” (COH-FIT), which involves almost 200 researchers from over 40 countries on six continents, aims to measure the impact of the COVID-19 on physical and mental health.

Read more

Predicting the severity of the illness using immune signatures

The research project “Defining the immune signatures in SARS-CoV-2 infected individuals in blood and tissues” aims to identity the biological markers that predict the severity of the illness.

Read more

Host determinants of severe COVID-19, learning from extreme cases

Supported by the SNF, this research project is based on the hypotheses that severe presentation of COVID-19 results from genetic predisposition and that transcriptomic profiling at an early stage may help predict adverse outcomes.

Read more

Identifying antibodies that can neutralise the coronavirus

As part of the “Corona Accelerated R&D in Europe” (CARE) programme, the Allergy and Immunology Department at CHUV has secured funding of almost 5 million Swiss francs for its work aimed at isolating antibodies that neutralise the coronavirus.

Read more

See all projects

Think health

The multi award-winning In Vivo magazine published by CHUV and produced in conjunction with the LargeNetwork agency offers an overview of medical innovation in French-speaking Switzerland and throughout the world. With the "Think health" editorial line, it first tackles the issues of health policies and the ethical aspects of modern medical practice. The magazine has a print run of 17,500 copies, is translated into English for the digital version, and features an infographic supplement called In Extenso.

Explore our magazine